Diagnosis of Epstein–Barr virus infection in clinical serum samples by an SPR biosensor assay

Label-free affinity biosensors offer a promising platform for the development of a new generation of medical diagnostic technologies. Nevertheless, when such sensors are used in complex biological media, adsorption of non-targeted medium components prevents the specific detection of the analyte. In...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biosensors & bioelectronics 2014-05, Vol.55, p.278-284
Hauptverfasser: Riedel, Tomáš, Rodriguez-Emmenegger, Cesar, de los Santos Pereira, Andres, Bědajánková, Anna, Jinoch, Pavel, Boltovets, Praskovia M., Brynda, Eduard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Label-free affinity biosensors offer a promising platform for the development of a new generation of medical diagnostic technologies. Nevertheless, when such sensors are used in complex biological media, adsorption of non-targeted medium components prevents the specific detection of the analyte. In this work, we introduce for the first time a biosensor assay based on surface plasmon resonance (SPR) capable of diagnosing different stages of Epstein–Barr virus (EBV) infections in clinical serum samples. This was achieved by simultaneous detection of the antibodies against three different antigens present in the virus. To prevent the interference of the fouling from serum during the measurement, the SPR chips were coated by an antifouling layer of a polymer brush of poly[oligo(ethylene glycol) methacrylate] grown by surface-initiated atom transfer radical polymerization. The bioreceptors were then attached via hybridization of complementary oligonucleotides. This allowed the sensor surface to be regenerated after measurement by disrupting the complementary pairs above the oligonucleotides' melting temperature and attaching new bioreceptors. In this way, the same sensing surface could be used repeatedly. The procedure used in this work will serve as a prototype strategy for the development of label-free affinity biosensors for diagnostics in blood serum or plasma samples. This is the first example of detection of marker of a disease in clinical serum samples by an optical affinity biosensor. •The first example of a label-free affinity biosensor detecting disease markers at their natural concentration in real clinical serum samples is presented.•The sensor is able to differentiate three stages of EBV infections in real non-spiked serum samples.•The regeneration of the sensor is possible under mild conditions.•The procedure presented herein provides a promising platform for the development of label-free affinity biosensors for diagnostics in blood serum or plasma samples.
ISSN:0956-5663
1873-4235
DOI:10.1016/j.bios.2013.12.011